Live Breaking News & Updates on Euroendocrine Ory Es0167733015

Stay updated with breaking news from Euroendocrine ory es0167733015. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oryzon Genomics S A : announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas

18 January 2023

ORYZON announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas

. | January 18, 2023 ....

United States , Comunidad Autonoma De Cataluna , Douglas Faller , Namrata Vijayvergia , Development Agreement , Us National Cancer Institute , Nuclear Dynamics , Cancer Epigenetics Institute , Fox Chase Cancer Center , Assistant Chief , Gastrointestinal Medical Oncology , Global Chief Medical Officer , Small Cell Lung Cancer , About Iadademstat , Cancer Cell , Fim Phase , Cooperative Research , Cancer Institute , Oryzon Genomics Sa Stock Exchange , Press Release , Euroendocrine Ory Es0167733015 ,